Tilray, Inc.

Most Recent

  • Person holding marijuana
    Cannabis

    Why Investors Should Buy Tilray Stock Before Reddit Traders Take Note

    By Mohit Oberoi, CFA
  • Tilray asks for shareholder vote for share count increase
    Cannabis

    Tilray Goes SNDL's Way and Bets on Marijuana Legalization With MedMen

    By Mohit Oberoi, CFA
  • Tilray building
    Cannabis

    Tilray (TLRY) Stock Rises on Q4 Earnings Beat, Good Pick for Investors

    By Ambrish Shah
  • Tilray Cannabis Company Lab
    Cannabis

    Tilray Stock Rises Sharply, Reddit Traders Push for Short Squeeze

    By Ambrish Shah
  • Tilray sign
    Cannabis

    Tilray Stock Has a Bright Outlook, Good Time to Buy the Dip

    By Ambrish Shah
  • Tilray building
    Cannabis

    Why Tilray (TLRY) Stock Is Rising Amid Reddit Chatter

    By Ambrish Shah
  • Person cutting cannabis flower
    Cannabis

    TLRY or SNDL: Which Is the Best Marijuana Stock to Buy Now?

    By Mohit Oberoi, CFA
  • Tilray logo over marijuana harvest
    Cannabis

    Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes

    By Rachel Curry
  • Marijuana plant
    Cannabis

    What the Tilray and Aphria Merger Means for Investors

    By Mohit Oberoi, CFA
  • Tilray sign
    Cannabis

    Tilray Stock Is Expected to Fall After Aphria Merger Date

    By Ambrish Shah
  • Tilray and Aphria logos
    Cannabis

    Latest Tilray and Aphria Merger News: Is It a Done Deal?

    By Mohit Oberoi, CFA
  • Person holding marijuana leaf
    Cannabis

    Tilray and Aphria Merger Date Nears, Don’t Ignore the Arbitrage

    By Mohit Oberoi, CFA
  • Worker at a cannabis farm
    Cannabis

    Why Investors Should Choose APHA Over TLRY Before the Merger

    By Mohit Oberoi, CFA
  • Tilray and Aphria logos
    Cannabis

    Tilray or Aphria: Which Stock Should You Buy Before the Merger?

    By Mohit Oberoi, CFA
  • Tilray's Stock Forecast 2021
    Cannabis

    Tilray Investors Are on a High, Stock Forecast Is Bearish in 2021

    By Mohit Oberoi, CFA
  • Tilray Is a Good Marijuana Stock to Buy on Dips
    Cannabis

    Tilray Is a Good Marijuana Stock for Investors to Buy on Dips

    By Ambrish Shah
  • is tilray a buy or sell
    Cannabis

    Is Tilray a Buy or Sell Amid Marijuana Uncertainty in 2021?

    By Mohit Oberoi, CFA
  • gettyimages
    Cannabis

    Are Cannabis Stocks a Good Investment Right Now?

    By Rachel Curry
  • is tilray a good stock to buy
    Cannabis

    Tilray Has Weak Top-Line Growth, Stock Isn't a Buy Right Now

    By Ambrish Shah
  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Canopy Growths EPS
    Company & Industry Overviews

    Analysts’ Estimates for Canopy Growth’s Earnings

    Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.

    By Adam Jones
  • uploads///man _
    Basic Materials

    Election Over, Market Still Undecided

    We know the nation is politically divided, and now the market is showing us its split personality as well.

    By JP Gravitt
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///Uhhled
    Earnings Report

    Cronos Group Invests in the Future

    Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Markets Rebound but Cannabis Stock Performance Is Mixed

    Markets rebounded today after the recent sell-off fueled by US-China trade tensions.

    By Adam Jones
  • uploads///Marijuana
    Cannabis

    Marijuana Legalization: More Americans Are Saying Yes

    Marijuana legalization is gathering steam as one of the key topics for the 2020 presidential election. Marijuana is still a federally controlled substance.

    By Sirisha Bhogaraju
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Aurora Cannabis’s Price Target Cut by 30%

    Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana Policy: Can California Shape It for the US?

    Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///green _
    Company & Industry Overviews

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.

    By Adam Jones
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///hand holding medicine
    Cannabis

    Why Medical Cannabis Lacks Scientific History

    Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.

    By Adam Jones
  • uploads///Canna
    Company & Industry Overviews

    Kamala Harris: Presidential Candidate for Legalizing Marijuana

    Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Cannabis Stocks Continue to Struggle on the Last Day of April

    The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

    By Adam Jones
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Price Target Update for Canopy Growth in January

    Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.

    By Adam Jones
  • Cannabis

    Marijuana Legalization: Minnesota Welcomes You!

    Marijuana legalization is an ongoing issue in the US. Currently, the District of Columbia and 11 states have legalized cannabis. Marijuana is still illegal for recreational use in Minnesota. However, the state’s voters might favor legalization. Minnesota voters are ready for marijuana legalization Minnesota hasn’t been able to come up with a legalization decision yet. […]

    By Adam Jones
  • uploads///cannabis stocks
    Cannabis

    Which Cannabis Stocks Have Lost More than 40% in 2019?

    The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

    By Sushree Mohanty
  • uploads///Opioid
    Cannabis

    Opioid Crisis: Is Cannabis Legalization a Good Idea?

    According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.

    By Sirisha Bhogaraju
  • uploads///cannabsis
    Cannabis

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

    By Sushree Mohanty
  • uploads/// Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    How Aurora Cannabis’s Valuations Compare to Its Peers’

    On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.

    By Adam Jones
  • uploads///marijuana hashish leaf flowerpot
    Earnings Report

    Canopy Growth Reported Its Q1 2019 Results on August 14

    Canopy Growth reported its earnings for the first quarter of 2019 on August 14. The company is one of the largest cannabis producers by capacity.

    By Adam Jones
  • uploads///IIPR
    Basic Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///arizona marijuana ballott
    Cannabis

    Arizona’s Marijuana Campaign Qualifies for November Ballot

    Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray’s Q2 Earnings Are Out: Did It Impress?

    In its Q2 earnings report today, Tilray reported a 371% YoY revenue increase to $45.9 million. Tilray beat analysts’ estimate of $41.1 million in revenue.

    By Sushree Mohanty
  • uploads///marijuana in june
    Cannabis

    Will Marijuana Stocks Continue to Surge in June?

    May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Are Its Q4 Results Good or Bad News?

    Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?

    By Sushree Mohanty
  • uploads///Tlry
    Company & Industry Overviews

    Tilray Makes a Bold Prediction on Cannabis Legalization in the US

    Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.

    By Adam Jones
  • uploads///
    Cannabis

    Medical Cannabis: NH Lawmakers Revoke Governor’s Veto

    New Hampshire legalized medical cannabis, but using cannabis for recreational purposes is still prohibited. The state legalized medical marijuana in 2013.

    By Rajiv Nanjapla
  • uploads///seedling _
    Company & Industry Overviews

    The Market Is Sinking and Taking the Cannabis Sector Along

    This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Why Tilray Cannabis Stock Popped Today

    On September 18, cannabis stock Tilray (TLRY) popped about 27% to an all-time high of $153.8 in the mid-day session.

    By Adam Jones
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • Cannabis

    New Gallup Poll on Marijuana Legalization Support

    A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]

    By Anjana Viswanathan
  • uploads///cannabis
    Company & Industry Overviews

    Cannabis Stocks: Will Tough Times End Soon?

    Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    One Chart That Shows What Makes Cannabis Attractive to Altria

    As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

    By Adam Jones
  • uploads///Tilray Gets US Governments Approval Importing CBD
    Cannabis

    Tilray Gets US Government’s Approval to Import CBD

    On August 8, Tilray announced that it had received approval to import cannabis into the US to conduct two clinical trials related to cannabidiol.

    By Adam Jones
  • uploads///Cannabis
    Cannabis

    Cannabis Legalization: Dark Clouds Loom Post Debate

    Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

    By Sushree Mohanty
  • uploads///cheers _
    Consumer

    Why Constellation Brands Has Fallen More than 12% Today

    On January 9, Constellation Brands (STZ) reported its third-quarter results before the market opened. The third quarter ended on November 30.

    By Jitendra Parashar
  • uploads///p
    Cannabis

    Curaleaf Stock: Latest Updates for Investors

    Lately, Curaleaf (CURLF) stock received some attention from cannabis investors. The company announced the acquisition of GR Companies on July 17. The acquisition would make Curaleaf one of the biggest cannabis companies. To learn more, read Curaleaf Will Soon Be the World’s Largest Cannabis Company. After the announcement, Curaleaf stock closed almost 17% higher at […]

    By Market Realist
  • uploads///AdobeStock_
    Cannabis

    Cannabis 2.0: What Products Can Canadians Expect?

    The Cannabis 2.0 era has officially started. Now, Canadians can legally access a host of cannabis-infused products like beverages, vapes, and edibles.

    By Margaret Patrick
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Comparing Cannabis Stocks’ Valuation Multiples in November

    Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Cannabis Corruption in the US: Trouble before Elections?

    Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.

    By Sushree Mohanty
  • uploads///Cannabis ETF Daily Performance
    Company & Industry Overviews

    Is Aurora Cannabis Looking at a Consumer Business Acquisition?

    Since Peltz has experience in the consumer market space, Aurora Cannabis is probably looking to make a deeper foray into the consumer space.

    By Adam Jones
  • Cannabis

    Bernie is Vocal About Legal Canadian Marijuana

    Making marijuana legal is currently one of the hot topics playing a dominant role in the 2020 US elections. With the US elections coming up, Bernie Sanders continues to show his support for legal cannabis. Currently, cannabis is legal for medical use across 33 states. Also, Bernie Sanders is a Democratic presidential candidate, who initially […]

    By Anjana Viswanathan
  • uploads///Marijuana
    Cannabis

    Will Coronavirus Target the Marijuana Industry Next?

    Cannabis companies that have operations in China, especially the ones that manufacture vape products, have been impacted by the coronavirus.

    By Sushree Mohanty
  • uploads///nebraska marijuana
    Cannabis

    Marijuana Legalization Hopes Rise in Nebraska for 2020

    Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’

    Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Canada’s Cannabis Oil Exports Rose More than 450% in 2019

    Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.

    By Rajiv Nanjapla
  • uploads///ACB_
    Cannabis

    Why Aurora Cannabis Plans to Sell Its Stake in Alcanna

    On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it agreed to sell its stake in Alcanna to a group of underwriters led by Cormark Securities.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Closing Facility Could Cost Tilray $28 Million in Non-Cash Charges

    On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.

    By Rajiv Nanjapla
  • uploads///Tilray_
    Cannabis

    Big News for Tilray: EU Campus Gets Third GMP Certification

    On May 27, Tilray (NASDAQ:TLRY) announced that its manufacturing facility in Cantanhede, Portugal, received the third EU GMP certification.

    By Rajiv Nanjapla
  • uploads///ACB_
    Cannabis

    Canopy Growth Stock Tanks Over 18% on Weak Q4 Earnings

    Today, Canopy Growth reported its results for the fourth quarter of fiscal 2020. The company reported revenues of 107.9 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///tilray analysts take
    Cannabis

    What Do Analysts Think about Tilray after Its Q1 Results?

    Tilray (NASDAQ:TLRY) posted its first-quarter earnings on May 11. The revenue growth was impressive in the first quarter.

    By Sushree Mohanty
  • uploads///hexo clock
    Cannabis

    Hexo Receives NYSE Warning for Listing, Clock Is Ticking

    On April 7, the NYSE sent a listing notification to Hexo. The warning said that the stock fell below the NYSE’s $1.00 share price continued listing standard.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Stock Surged 68% on May 15

    Aurora Cannabis (NYSE:ACB) reported its third-quarter results on May 14. The earnings report was a surprise for most analysts and investors.

    By Sushree Mohanty
  • uploads///cronos group earnings and outlook
    Cannabis

    Cronos: Analysts Cut Target Price, Raymond James Still Bullish

    Cronos Group (NASDAQ:CRON) reported its results for the first quarter of fiscal 2020 on May 8. The revenue growth was stronger.

    By Sushree Mohanty
  • uploads///aurora cannabis q results
    Cannabis

    Aurora Cannabis to Report Q3 Earnings, Stock Falls after Split

    Aurora Cannabis (NYSE:ACB) announced a reverse stock split in April. The stock split happened on Monday and the stock took a hit.

    By Sushree Mohanty
  • uploads///TLRY
    Cannabis

    Tilray Posts Q1 Results, Stock Falls, and Net Losses Widen

    On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.

    By Rajiv Nanjapla
  • uploads///marijuana new zealand
    Cannabis

    Marijuana Legalization: New Zealand Has a Final Proposal

    In New Zealand, marijuana legalization’s fate depends on the September general elections. The country has a final bill to put on the ballot.

    By Sushree Mohanty
  • uploads///tilray_
    Cannabis

    Tilray’s Q1 Earnings Could Boost Its Stock Price

    The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.

    By Rajiv Nanjapla
  • uploads///matteo paganelli MqISkmiLGc unsplash
    Cannabis

    Is Aphria a Viable Investment in the Cannabis Space?

    Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive.

    By Amit Singh
  • uploads///tilray jefferies downgrade
    Cannabis

    Tilray Falls 6% after Jefferies Downgraded the Stock

    Jefferies went bullish on Aphria and bearish on Tilray. Notably, Tilray stock fell 6% on Thursday after Jefferies downgraded the stock.

    By Sushree Mohanty
  • uploads///aurora and hexo end of road
    Cannabis

    End of the Road for Aurora Cannabis and Hexo Stock?

    Cannabis stocks looked like promising investment options. However, the stocks have eroded a significant amount of investors’ wealth over the past year.

    By Amit Singh
  • uploads///aurora cannabis stock split
    Cannabis

    Aurora Cannabis Stock Falls on Reverse Stock Split Decision

    Aurora Cannabis announced its plan to raise capital and strengthen its liquidity position through a reverse stock split amid the financial crisis.

    By Sushree Mohanty
  • uploads///organigram q results
    Cannabis

    OrganiGram: Analysts Aren’t Hopeful about Its Q2 Earnings

    OrganiGram will report its results for the second quarter of fiscal 2020 on April 14 before the market opens. Analysts aren’t hopeful about the results.

    By Sushree Mohanty
  • uploads///joe biden marijuana
    Cannabis

    Should Joe Biden Support Marijuana Legalization?

    Marijuana is gaining a lot of attention amid the coronavirus pandemic. Many people think that Joe Biden should support marijuana legalization.

    By Sushree Mohanty
  • uploads///kushco
    Cannabis

    KushCo Posted Disappointing Q2 Results, Stock Rose 8%

    KushCo’s second-quarter revenue was almost in line with analysts’ estimates. The company reported revenue of $30.14 million.

    By Sushree Mohanty
  • uploads///organigram analysts revise
    Cannabis

    OrganiGram: Analysts Revise 2020 Estimates in April

    Analysts have lowered the revenue estimates for OrganiGram for fiscal 2020. Analysts expect the revenue to be around 127 million Canadian dollars.

    By Sushree Mohanty
  • uploads///tilray survive coronavirus
    Cannabis

    Will Tilray Recover in 2020 amid the COVID-19 Outbreak?

    Tilray (NASDAQ:TLRY) had a disastrous 2019—the stock lost 75.7% of its value. So far, 2020 hasn’t been pretty either for the stock.

    By Sushree Mohanty
  • uploads///Aphria_OGI
    Cannabis

    Why Did Bank of America Upgrade Aphria and OrganiGram?

    On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.

    By Rajiv Nanjapla
  • uploads///tennessee marijuana poison pill
    Cannabis

    Tennessee Approved Medical Marijuana, Included a Poison Pill

    The Tennessee Senate passed a medical marijuana bill due to the rising benefits of medical marijuana. However, the bill includes a poison pill.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Are Marijuana Stocks a Good Investment in March?

    Investing in a slow-growing industry like marijuana requires patience and a stomach to handle the risk. As a result, investors should be cautious.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Sales Rise in Illinois, Other States Notice

    Marijuana became legal in Illinois on January 1, 2020. As expected, retail cannabis sales started soaring as soon as legal shops opened their doors.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Mike Bloomberg Doesn’t Support Marijuana Legalization

    Overall, Mike Bloomberg has the same view as President Trump and Joe Biden when it comes to marijuana legalization. He strongly opposes legalization.

    By Sushree Mohanty
  • uploads///tilray target price cut
    Cannabis

    Tilray’s Q4 Earnings Force Analysts to Cut Its Target Price

    Tilray (NASDAQ:TLRY) reported dismal results for the fourth quarter of fiscal 2019 on Tuesday. The losses widened in the fourth quarter.

    By Sushree Mohanty
  • uploads///vermont recreational cannabis
    Cannabis

    Vermont House Approves Recreational Cannabis Sales

    Medical and recreational cannabis is legal in Vermont. Recently, the Vermont House of Representatives approved cannabis sales in 2020.

    By Sushree Mohanty
  • uploads///connecticut marijuana public
    Cannabis

    Connecticut Will Hear Public’s View on Marijuana Legalization

    Marijuana legalization is a hot top topic in the US as the presidential 2020 election gets closer. Legalization is a priority for Connecticut in 2020.

    By Sushree Mohanty
  • uploads///tilray q results
    Cannabis

    Tilray’s Q4 Losses Widen, Cannabis Sector Struggles

    Tilray reported wide losses in its results for the fourth quarter of fiscal 2019 after markets closed on Monday. The stock closed 6.3% higher yesterday.

    By Sushree Mohanty
  • uploads///canopy growth
    Cannabis

    Canopy Growth: No More Cash Investment from Constellation

    Canopy Growth has enough cash on hand to survive the financial chaos in the cannabis space. Constellation Brands decided not to increase its investment.

    By Sushree Mohanty
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.